Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

The inhibitor affects androgen metabolism but not ovarian function.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Baricitinib may not always prevent relapse in alopecia areata.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Ritlecitinib can help about 14,000 people with severe hair loss.

t-Flavanone may help hair growth by reducing a specific protein's activity in skin cells.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Pexidartinib often causes liver issues and fatigue, especially in women.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.